88 related articles for article (PubMed ID: 22681384)
61. Sex Differences in Protein Expression and Their Perturbations in Amniotic Fluid Cells of Down Syndrome Fetuses.
Liu Y; Zhang X; Zhang L; Zhu H; Chen J; Lin Z; Zhou B; Liu S; Wang H; Sun H
ACS Omega; 2022 Oct; 7(40):35981-35992. PubMed ID: 36249375
[TBL] [Abstract][Full Text] [Related]
62. Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndrome.
Cho CK; Drabovich AP; Karagiannis GS; Martínez-Morillo E; Dason S; Dimitromanolakis A; Diamandis EP
Clin Proteomics; 2013 Feb; 10(1):2. PubMed ID: 23394617
[TBL] [Abstract][Full Text] [Related]
63. Bioinformatics characterization of differential proteins in serum of mothers carrying Down syndrome fetuses: combining bioinformatics and ELISA.
Yu B; Zhang B; Shi Y; Shao SH; Wang QW; Huang RP; Yang YQ
Arch Med Sci; 2012 May; 8(2):183-91. PubMed ID: 22661988
[TBL] [Abstract][Full Text] [Related]
64. Redefining serological diagnostics with immunoaffinity proteomics.
Walter J; Eludin Z; Drabovich AP
Clin Proteomics; 2023 Oct; 20(1):42. PubMed ID: 37821808
[TBL] [Abstract][Full Text] [Related]
65. Rational Design and Development of SARS-CoV-2 Serological Diagnostics by Immunoprecipitation-Targeted Proteomics.
Fu Z; Rais Y; Dara D; Jackson D; Drabovich AP
Anal Chem; 2022 Sep; 94(38):12990-12999. PubMed ID: 36095284
[TBL] [Abstract][Full Text] [Related]
66. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants.
Rais Y; Fu Z; Drabovich AP
Clin Proteomics; 2021 Aug; 18(1):19. PubMed ID: 34384361
[TBL] [Abstract][Full Text] [Related]
67. Mapping Isoform Abundance and Interactome of the Endogenous TMPRSS2-ERG Fusion Protein by Orthogonal Immunoprecipitation-Mass Spectrometry Assays.
Fu Z; Rais Y; Bismar TA; Hyndman ME; Le XC; Drabovich AP
Mol Cell Proteomics; 2021; 20():100075. PubMed ID: 33771697
[TBL] [Abstract][Full Text] [Related]
68. Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.
Drabovich AP; Saraon P; Drabovich M; Karakosta TD; Dimitromanolakis A; Hyndman ME; Jarvi K; Diamandis EP
Mol Cell Proteomics; 2019 Sep; 18(9):1807-1823. PubMed ID: 31249104
[TBL] [Abstract][Full Text] [Related]
69. Identification of TEX101-associated Proteins Through Proteomic Measurement of Human Spermatozoa Homozygous for the Missense Variant rs35033974.
Schiza C; Korbakis D; Jarvi K; Diamandis EP; Drabovich AP
Mol Cell Proteomics; 2019 Feb; 18(2):338-351. PubMed ID: 30429210
[TBL] [Abstract][Full Text] [Related]
70. Discovery of a Human Testis-specific Protein Complex TEX101-DPEP3 and Selection of Its Disrupting Antibodies.
Schiza C; Korbakis D; Panteleli E; Jarvi K; Drabovich AP; Diamandis EP
Mol Cell Proteomics; 2018 Dec; 17(12):2480-2495. PubMed ID: 30097533
[TBL] [Abstract][Full Text] [Related]
71. Advances in targeted proteomics and applications to biomedical research.
Shi T; Song E; Nie S; Rodland KD; Liu T; Qian WJ; Smith RD
Proteomics; 2016 Aug; 16(15-16):2160-82. PubMed ID: 27302376
[TBL] [Abstract][Full Text] [Related]
72. Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers.
Cretu D; Liang K; Saraon P; Batruch I; Diamandis EP; Chandran V
Clin Proteomics; 2015; 12(1):1. PubMed ID: 25678896
[TBL] [Abstract][Full Text] [Related]
73. Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry.
Cretu D; Prassas I; Saraon P; Batruch I; Gandhi R; Diamandis EP; Chandran V
Clin Proteomics; 2014; 11(1):27. PubMed ID: 25097465
[TBL] [Abstract][Full Text] [Related]
74. Specificity and sensitivity of S100B levels in amniotic fluid for Down syndrome diagnosis.
Tort AB; Portela LV; da Purificação Tavares M; Gonçalves CA; Netto C; Giugliani R; Souza DO
Life Sci; 2004 Dec; 76(4):379-84. PubMed ID: 15530500
[TBL] [Abstract][Full Text] [Related]
75. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
Dick PT
CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
[TBL] [Abstract][Full Text] [Related]
76. Decreased amniotic fluid leptin levels in the second trimester in Down's syndrome.
Choi TY; Kim S; An BM; Jeong SY; Moon HS; Joo BS
Fetal Diagn Ther; 2009; 26(4):195-9. PubMed ID: 19940449
[TBL] [Abstract][Full Text] [Related]
77. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery.
Cho CK; Smith CR; Diamandis EP
J Proteome Res; 2010 Jul; 9(7):3574-82. PubMed ID: 20459121
[TBL] [Abstract][Full Text] [Related]
78. Down syndrome screening: imagining the screening test of the future.
Koster MP; Heetkamp KM; Pennings JL; de Vries A; Visser GH; Schielen PC
Expert Rev Mol Diagn; 2010 May; 10(4):445-57. PubMed ID: 20465499
[TBL] [Abstract][Full Text] [Related]
79. Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples.
Martínez-Morillo E; Cho CK; Drabovich AP; Shaw JL; Soosaipillai A; Diamandis EP
J Proteome Res; 2012 Jul; 11(7):3880-7. PubMed ID: 22681384
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
